CNBX Pharmaceuticals Inc.
CNBX
$0.00
$0.000.00%
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 162.80K | 73.00K | 64.00K | 129.70K | 40.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 162.80K | 73.00K | 64.00K | 129.70K | 40.40K |
| Operating Income | -162.80K | -73.00K | -64.00K | -129.70K | -40.40K |
| Income Before Tax | -154.20K | -44.10K | -113.70K | -150.10K | -59.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -154.20K | -44.10K | -113.70K | -150.10K | -59.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -154.20K | -44.10K | -113.70K | -150.10K | -59.70K |
| EBIT | -162.80K | -73.00K | -64.00K | -129.70K | -40.40K |
| EBITDA | -- | -- | -- | -111.70K | -22.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.32B | 931.02M | 732.86M | 256.17M | 42.60M |
| Average Diluted Shares Outstanding | 1.32B | 931.02M | 732.86M | 256.17M | 42.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |